West Pharmaceutical Services, Inc. (WST)
NYSE: WST · IEX Real-Time Price · USD
317.92
+1.58 (0.50%)
At close: Jul 19, 2024, 4:00 PM
317.94
+0.02 (0.01%)
After-hours: Jul 20, 2024, 12:58 PM EDT
WST Revenue
West Pharmaceutical Services had revenue of $2.93B in the twelve months ending March 31, 2024, with 1.56% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $695.40M. In the year 2023, West Pharmaceutical Services had annual revenue of $2.95B with 2.18% growth.
Revenue (ttm)
$2.93B
Revenue Growth
+1.56%
P/S Ratio
7.91
Revenue / Employee
$276,283
Employees
10,600
Market Cap
23.16B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
Dec 31, 2019 | 1.84B | 122.50M | 7.13% |
Dec 31, 2018 | 1.72B | 118.30M | 7.40% |
Dec 31, 2017 | 1.60B | 90.00M | 5.96% |
Dec 31, 2016 | 1.51B | 109.30M | 7.81% |
Dec 31, 2015 | 1.40B | -21.60M | -1.52% |
Dec 31, 2014 | 1.42B | 53.00M | 3.87% |
Dec 31, 2013 | 1.37B | 102.00M | 8.05% |
Dec 31, 2012 | 1.27B | 74.10M | 6.21% |
Dec 31, 2011 | 1.19B | 87.60M | 7.93% |
Dec 31, 2010 | 1.10B | 49.00M | 4.64% |
Dec 31, 2009 | 1.06B | 4.60M | 0.44% |
Dec 31, 2008 | 1.05B | 31.00M | 3.04% |
Dec 31, 2007 | 1.02B | 106.80M | 11.69% |
Dec 31, 2006 | 913.30M | 213.60M | 30.53% |
Dec 31, 2005 | 699.70M | 158.10M | 29.19% |
Dec 31, 2004 | 541.60M | 58.20M | 12.04% |
Dec 31, 2003 | 483.40M | 70.60M | 17.10% |
Dec 31, 2002 | 412.80M | 20.50M | 5.23% |
Dec 31, 2001 | 392.30M | 19.80M | 5.32% |
Dec 31, 2000 | 372.50M | -23.30M | -5.89% |
Dec 31, 1999 | 395.80M | -53.90M | -11.99% |
Dec 31, 1998 | 449.70M | -2.80M | -0.62% |
Dec 31, 1997 | 452.50M | -6.30M | -1.37% |
Dec 31, 1996 | 458.80M | 45.90M | 11.12% |
Dec 31, 1995 | 412.90M | 47.80M | 13.09% |
Dec 31, 1994 | 365.10M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 220.57B |
Koninklijke Philips | 20.19B |
Teva Pharmaceutical | 16.00B |
ICON PLC | 8.23B |
Zimmer Biomet Holdings | 7.45B |
STERIS | 5.14B |
Mettler-Toledo International | 3.79B |
BioNTech SE | 2.97B |
WST News
- 11 days ago - West to Host Second-Quarter 2024 Conference Call - PRNewsWire
- 7 weeks ago - West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy - PRNewsWire
- 7 weeks ago - West to Participate in Upcoming Investor Conference - PRNewsWire
- 3 months ago - West Pharma posts beat-and-raise quarter aided by strong demand for injectables - Reuters
- 3 months ago - West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend - PRNewsWire
- 3 months ago - Ex-Dividend Reminder: Lennar, Lowe's And West Pharmaceutical - Forbes
- 3 months ago - West to Host First-Quarter 2024 Conference Call - PRNewsWire
- 5 months ago - West to Participate in Upcoming Investor Conferences - PRNewsWire